POSC288 Evidence Requirements in the Regulatory and Reimbursement Processes of Digital Therapeutics: Insights from the US, EU4 and UK

Jan 1, 2022, 00:00 AM
10.1016/j.jval.2021.11.949
https://www.valueinhealthjournal.com/article/S1098-3015(21)02744-3/fulltext
Section Title :
Section Order : 10484
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02744-3&doi=10.1016/j.jval.2021.11.949
HEOR Topics :
Tags :
Regions :